• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影像学检查能否帮助选择心力衰竭患者植入 ICD?

Will imaging assist in the selection of patients with heart failure for an ICD?

机构信息

Division of Cardiovascular Diseases, University of Cincinnati College of Medicine, and E. L. Saenger Radioisotope Laboratory, University Hospital of Cincinnati, Cincinnati, Ohio 45267-0542, USA.

出版信息

JACC Cardiovasc Imaging. 2010 Jan;3(1):101-10. doi: 10.1016/j.jcmg.2009.07.013.

DOI:10.1016/j.jcmg.2009.07.013
PMID:20129539
Abstract

Sudden cardiac death remains the leading cause of death in the U.S. A left ventricular ejection fraction (LVEF)<30% to 35% identifies a population of patients at increased risk for sudden cardiac death. Once identified, an implantable cardioverter-defibrillator (ICD) is effective in reducing the occurrence of sudden cardiac death. Yet in a substantial proportion of patients who receive an ICD based on reduced LVEF, the device never delivers therapy. Furthermore, the majority of patients who die suddenly do not qualify for ICD placement under current LVEF-based criteria in the guidelines. This review considers the potential role of cardiac imaging in improving the selection of patients most likely to benefit from an ICD. The presence of myocardial scar and/or unrevascularized myocardial ischemia provides an important substrate for the occurrence of potentially fatal ventricular arrhythmias. The presence of clinical heart failure further increases the risk of ventricular arrhythmia. The sympathetic nervous system provides an important trigger for major arrhythmic events, both through global overactivity and through regional heterogeneity of sympathetic activity. A mismatch of myocardial perfusion and innervation may pose a particularly great risk. Imaging modalities provide unique opportunities to investigate the anatomic and pathophysiologic substrates, as well as the triggering effects of cardiac sympathetic innervation. Combining imaging and electrophysiologic modalities offers promise for improved accuracy in future selection of patients with heart failure for ICD placement.

摘要

心脏性猝死仍然是美国的主要死亡原因。左心室射血分数(LVEF)<30%至 35%确定了一群发生心脏性猝死风险增加的患者。一旦确定,植入式心脏复律除颤器(ICD)可有效降低心脏性猝死的发生。然而,在很大一部分接受基于降低 LVEF 的 ICD 的患者中,该设备从未提供治疗。此外,大多数发生突然死亡的患者不符合当前指南中基于 LVEF 的标准对 ICD 进行定位的条件。这篇综述考虑了心脏成像在改善最有可能从 ICD 中受益的患者选择方面的潜在作用。心肌瘢痕和/或未再血管化的心肌缺血为潜在致命性室性心律失常的发生提供了重要的基质。临床心力衰竭的存在进一步增加了室性心律失常的风险。交感神经系统通过整体过度活跃和交感神经活动的局部异质性,为主要心律失常事件提供了重要的触发因素。心肌灌注和神经支配的不匹配可能构成特别大的风险。成像方式为研究解剖和病理生理基质以及心脏交感神经支配的触发作用提供了独特的机会。结合成像和电生理方式有望提高未来对心力衰竭患者进行 ICD 定位的准确性。

相似文献

1
Will imaging assist in the selection of patients with heart failure for an ICD?影像学检查能否帮助选择心力衰竭患者植入 ICD?
JACC Cardiovasc Imaging. 2010 Jan;3(1):101-10. doi: 10.1016/j.jcmg.2009.07.013.
2
Non-invasive imaging to identify susceptibility for ventricular arrhythmias in ischaemic left ventricular dysfunction.用于识别缺血性左心室功能障碍患者室性心律失常易感性的非侵入性成像技术。
Heart. 2016 Jun 1;102(11):832-40. doi: 10.1136/heartjnl-2015-308467. Epub 2016 Feb 3.
3
Can QRS scoring predict left ventricular scar and clinical outcomes?QRS 记分能否预测左心室瘢痕和临床结局?
Europace. 2013 Jul;15(7):1034-41. doi: 10.1093/europace/eut014. Epub 2013 Mar 14.
4
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.植入式心脏复律除颤器治疗的风险分层:可穿戴式心脏除颤器的作用。
Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31.
5
Added Value of 3- Versus 2-Dimensional Echocardiography Left Ventricular Ejection Fraction to Predict Arrhythmic Risk in Patients With Left Ventricular Dysfunction.二维与三维超声心动图左心室射血分数对左心室功能障碍患者心律失常风险预测的附加价值。
JACC Cardiovasc Imaging. 2019 Oct;12(10):1917-1926. doi: 10.1016/j.jcmg.2018.07.011. Epub 2018 Sep 12.
6
Noninvasive imaging markers associated with sudden cardiac death.与心源性猝死相关的非侵入性成像标志物。
Trends Cardiovasc Med. 2016 May;26(4):348-60. doi: 10.1016/j.tcm.2015.10.003. Epub 2015 Oct 17.
7
The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy.需要修改患者选择标准,以提高植入式心脏复律除颤器用于非缺血性扩张型心肌病患者一级预防心源性猝死的获益。
Europace. 2013 Dec;15(12):1693-701. doi: 10.1093/europace/eut228. Epub 2013 Aug 14.
8
Barriers to patients eligible for screening investigations and insertion of primary prevention implantable cardioverter defibrillators.适合进行筛查检查及植入一级预防植入式心脏复律除颤器的患者所面临的障碍。
Europace. 2014 Nov;16(11):1575-9. doi: 10.1093/europace/euu054. Epub 2014 Mar 25.
9
[Arrhythmia risk stratification in patients with heart failure. Foreword].[心力衰竭患者的心律失常风险分层。前言]
Ital Heart J Suppl. 2001 Dec;2(12):1263-4.
10
Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.延长器械寿命对植入式心脏转复除颤器治疗长期成本的影响:具有 15 年时间范围的建模研究。
Europace. 2013 Oct;15(10):1453-62. doi: 10.1093/europace/eut133. Epub 2013 May 21.

引用本文的文献

1
Principles and techniques of imaging in identifying the substrate of ventricular arrhythmia.识别室性心律失常基质的成像原理与技术
J Nucl Cardiol. 2016 Apr;23(2):218-34. doi: 10.1007/s12350-015-0344-8. Epub 2015 Dec 14.
2
It's not all in the numbers.这并非全由数字决定。
J Nucl Cardiol. 2016 Jun;23(3):436-41. doi: 10.1007/s12350-015-0105-8. Epub 2015 Mar 24.
3
Nuclear cardiology: 2014 innovations and developments.核心脏病学:2014年的创新与发展。
Methodist Debakey Cardiovasc J. 2014 Jul-Sep;10(3):163-71. doi: 10.14797/mdcj-10-3-163.
4
Cardiac imaging in evaluating patients prone to sudden death.心脏成像在评估猝死易患患者中的应用
Indian Heart J. 2014 Jan-Feb;66 Suppl 1(Suppl 1):S61-70. doi: 10.1016/j.ihj.2013.12.012. Epub 2014 Jan 12.
5
Cardiac autonomic imaging with SPECT tracers.SPECT 示踪剂的心脏自主成像。
J Nucl Cardiol. 2013 Feb;20(1):128-43; quiz 146. doi: 10.1007/s12350-012-9655-1.
6
What will be the role of I-123 MIBG in improving the outcome of medically treated heart failure patients?I-123间碘苄胍在改善药物治疗的心力衰竭患者的治疗效果中会起到什么作用?
J Nucl Cardiol. 2012 Dec;19(6):1198-205; quiz 1206-10. doi: 10.1007/s12350-012-9612-z.
7
Non-invasive risk assessment in patients with chronic kidney disease.慢性肾病患者的非侵入性风险评估
J Nucl Cardiol. 2011 May;18(3):472-85. doi: 10.1007/s12350-011-9359-y.